Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 36151 | 85 | 26.1 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
| 697 | 2 | MEAN PLATELET VOLUME//PLATELETS//HEMATOLOGY | 13039 |
| 36151 | 1 | NIPECOTAMIDES//CARBAMOYLPIPERIDINES//AMINOMETHYLPIPERIDINE | 85 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | NIPECOTAMIDES | authKW | 1122631 | 6% | 63% | 5 |
| 2 | CARBAMOYLPIPERIDINES | authKW | 718486 | 2% | 100% | 2 |
| 3 | AMINOMETHYLPIPERIDINE | authKW | 359243 | 1% | 100% | 1 |
| 4 | ANILIDES OF NIPECOTIC ACID | authKW | 359243 | 1% | 100% | 1 |
| 5 | ANTITHROMBOTIC NIPECOTAMIDES | authKW | 359243 | 1% | 100% | 1 |
| 6 | BIOQUIM ENFERMEDADES | address | 359243 | 1% | 100% | 1 |
| 7 | BISCARBAMOYLPIPERIDINE | authKW | 359243 | 1% | 100% | 1 |
| 8 | COLLAGEN RELATED PEPTIDE PLATELET ACTIVATION | authKW | 359243 | 1% | 100% | 1 |
| 9 | CYCLICGUANOSINE MONOPHOSPHATE CGMP | authKW | 359243 | 1% | 100% | 1 |
| 10 | DIENCIAS SALUD | address | 359243 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Hematology | 543 | 25% | 0% | 21 |
| 2 | Peripheral Vascular Diseases | 532 | 24% | 0% | 20 |
| 3 | Chemistry, Medicinal | 179 | 14% | 0% | 12 |
| 4 | Biophysics | 161 | 16% | 0% | 14 |
| 5 | Pharmacology & Pharmacy | 119 | 24% | 0% | 20 |
| 6 | Biochemistry & Molecular Biology | 50 | 24% | 0% | 20 |
| 7 | Pathology | 17 | 5% | 0% | 4 |
| 8 | Toxicology | 15 | 5% | 0% | 4 |
| 9 | Chemistry, Organic | 12 | 7% | 0% | 6 |
| 10 | Physiology | 4 | 4% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOQUIM ENFERMEDADES | 359243 | 1% | 100% | 1 |
| 2 | DIENCIAS SALUD | 359243 | 1% | 100% | 1 |
| 3 | DRUG EVALUAT CHEM PHARMACEUT DEV | 359243 | 1% | 100% | 1 |
| 4 | SEC 10 | 359243 | 1% | 100% | 1 |
| 5 | UNIDAD INVEST MED TROMBOSIS HMOSTASIA ATEROGENE | 359243 | 1% | 100% | 1 |
| 6 | DIPARTIMENTO MED ONCOL | 71847 | 1% | 20% | 1 |
| 7 | SERV IMMUNOTRASFUS ANAL CLIN | 32657 | 1% | 9% | 1 |
| 8 | MED UNIT METAB DIS | 14368 | 1% | 4% | 1 |
| 9 | UNIT STUDY BIOMEMBRANES | 10564 | 1% | 3% | 1 |
| 10 | TEKNIKOKULLAR | 7981 | 1% | 2% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | THROMBOSIS RESEARCH | 5063 | 14% | 0% | 12 |
| 2 | MEDICAL PROGRESS THROUGH TECHNOLOGY | 4646 | 2% | 1% | 2 |
| 3 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 2509 | 5% | 0% | 4 |
| 4 | BIOCHIMICA ET BIOPHYSICA ACTA | 1514 | 13% | 0% | 11 |
| 5 | THROMBOSIS AND HAEMOSTASIS | 1294 | 7% | 0% | 6 |
| 6 | FUNDAMENTAL AND APPLIED TOXICOLOGY | 678 | 2% | 0% | 2 |
| 7 | PHARMACEUTICA ACTA HELVETIAE | 515 | 1% | 0% | 1 |
| 8 | ARTERIOSCLEROSIS | 499 | 1% | 0% | 1 |
| 9 | ACTA HAEMATOLOGICA JAPONICA | 483 | 1% | 0% | 1 |
| 10 | CHIRALITY | 468 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | ZHENG, XZ , SALGIA, SR , THOMPSON, WB , DILLINGHAM, EO , BOND, SE , FENG, ZX , PRASAD, KR , GOLLAMUDI, R , (1995) DESIGN AND SYNTHESIS OF PIPERIDINE-3-CARBOXAMIDES AS HUMAN PLATELET-AGGREGATION INHIBITORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 38. ISSUE 1. P. 180-188 | 15 | 79% | 9 |
| 2 | LASSLO, A , (1990) NOVEL PERSPECTIVES FOR STRUCTURING SYNTHETIC INHIBITORS OF HUMAN BLOOD-PLATELET AGGREGATION AND POTENTIAL ANTITHROMBOTIC AGENTS.RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY. VOL. 69. ISSUE 2. P. 133-162 | 18 | 82% | 7 |
| 3 | GUO, ZM , ZHENG, XZ , THOMPSON, W , DUGDALE, M , GOLLAMUDI, R , (2000) NEW CARBAMOYLPIPERIDINES AS HUMAN PLATELET AGGREGATION INHIBITORS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 8. ISSUE 5. P. 1041 -1058 | 14 | 64% | 10 |
| 4 | HAN, GZ , BOND, SE , LAWRENCE, WH , DILLINGHAM, EO , ZHENG, XZ , GOLLAMUDI, R , (1994) SYNERGISTIC ANTIPLATELET EFFECTS OF A NIPECOTAMIDE A-1C AND LOW-DOSE ASPIRIN.GENERAL PHARMACOLOGY. VOL. 25. ISSUE 7. P. 1373-1379 | 15 | 71% | 0 |
| 5 | HAN, GZ , BANNERMAN, D , HANDA, RK , DILLINGHAM, EO , LAWRENCE, WH , GOLLAMUDI, R , (1997) ANTIPLATELET EFFECTS OF R,S-(MESO)-ALPHA, ALPHA'-BIS[3-(N,N-DIETHYLCARBAMOYL)PIPERIDINO]-P-XYLENE EX VIVO IN THE DOG AND IN VIVO IN THE MOUSE.GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM. VOL. 28. ISSUE 4. P. 617-621 | 11 | 85% | 0 |
| 6 | DILLINGHAM, EO , LASSLO, A , GOLLAMUDI, R , BOND, SE , CARTERBURKS, G , (1990) THE EFFECT OF CARBAMOYLPIPERIDINE AND NIPECOTOYLPIPERAZINE ANALOGS ON ADP-STIMULATED HUMAN THROMBOCYTE AGGREGATION AND PLATELET FACTOR-III AVAILABILITY.RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY. VOL. 67. ISSUE 2. P. 179-199 | 13 | 93% | 0 |
| 7 | ZHENG, XZ , GOLLAMUDI, R , (1997) DESIGN AND SYNTHESIS OF ANTIPLATELET NIPECOTAMIDES WITH A DUAL MECHANISM OF ACTION.MEDICINAL CHEMISTRY RESEARCH. VOL. 7. ISSUE 4. P. 219-227 | 13 | 68% | 1 |
| 8 | GOLLAMUDI, R , FENG, Z , DILLINGHAM, EO , BOND, SE , HAN, G , SALGIA, S , (1993) ENANTIOSELECTIVE ANTIPLATELET ACTIONS OF NIPECOTAMIDES.THROMBOSIS RESEARCH. VOL. 69. ISSUE 4. P. 361-367 | 11 | 85% | 2 |
| 9 | GOLLAMUDI, R , DILLINGHAM, EO , BOND, SE , (1994) INHIBITION OF AGONIST-INDUCED RISE IN PLATELET CA2+ BY ANTITHROMBOTIC NIPECOTAMIDES.BLOOD COAGULATION & FIBRINOLYSIS. VOL. 5. ISSUE 3. P. 375-383 | 15 | 58% | 2 |
| 10 | ZHENG, XZ , DAY, C , GOLLAMUDI, R , (1995) SYNTHESIS OF STEREOISOMERS OF ANTITHROMBOTIC NIPECOTAMIDES.CHIRALITY. VOL. 7. ISSUE 2. P. 90-95 | 8 | 100% | 9 |
Classes with closest relation at Level 1 |